Greg Peet elected as Chairman of Vigil Health Solutions

Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).

Following the AGM, Vigil's Board of Directors appointed the remaining officers of the Company and Board Committee members. Troy Griffiths was re-appointed President and Chief Executive Officer, Nicola Chalmers, Chief Financial Officer and Secretary, Jacquie Brennan, Vice President, Operations and Steven Smith, Vice President, Research and Development. Stephen Martin (as Chairman), Greg Peet and Tanner Philp were appointed to the Audit Committee. Harry Jaako (as Chairman), Stephen Martin and Greg Peet were appointed to the Governance and Compensation Committee.

In addition, the Board granted an aggregate amount of 1,732,000 stock options pursuant to Vigil's Omnibus Share Compensation Plan. Of the total, 360,000 options were granted to Directors, these vest 25% on grant and 25% every six months following, a further 960,000 were granted to Officers of the Company, these vest over a 4-year period, in equal quarterly installments, starting 12 months from issue. The remaining 412,000 options were granted to employees under the same vesting terms as the Officers of the Company. These options are exercisable at a price of $0.10 per share and expire August 20, 2014.

Further, the Board granted 475,000 deferred stock units (DSUs) pursuant to Vigil's Omnibus Share Compensation Plan to the Directors of Vigil subject to the approval of the TSX Venture Exchange. The DSUs vest in four equal installments every six months commencing on the grant date and only become exercisable upon ceasing to be a Director of Vigil or, upon a change of control. Each DSU may be settled for one common share, the cash equivalent, or a combination of both. Directors receive no cash or other compensation for their services as a Director outside of the grant of DSUs and options.

After the addition of these options and the DSUs, the Company has an aggregate of 9,761,600 options and stock units outstanding representing 9.8% of shares issued.

http://www.vigil.com

Posted in:

Tags: ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.